Artelo Biosciences competitorsClear all

Artelo Biosciences's top competitors include LGC, Chiasma, UCB and Keryx Biopharmaceuticals.
Artelo Biosciences
Artelo Biosciences
Artelo Biosciences is a biopharmaceutical company focused on the development and commercialization of therapeutics targeting the endocannabinoid system.
LGC
LGC
LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.
Chiasma
Chiasma
Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases.
UCB
UCB
Patients are at the center of everything we do. At UCB, we are Inspired by patients. Driven by science.
Keryx Biopharmaceuticals
Keryx Biopharmaceuticals
Keryx Biopharmaceuticals is a biopharmaceutical company focused on the development of products for the treatment of renal diseases.
Founding Date
Founding Date
2017
Founding Date
1842
Founding Date
2001
Founding Date
1928
Founding Date
1998
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
San Diego, US HQ
Dublin 2, IE
Locations
Teddington, GB HQ
Sofia, BG
Nanjing Shi, CN
Risskov, DK
see more
Locations
Needham, US HQ
Ness Ziona, IL
Waltham, US
Locations
Anderlecht, BE HQ
Locations
New York, US HQ
Cambridge, US
Employees
Employees
14
Employees
901
Employees
48167% increase
Employees
7,6069% increase
Employees
1892% decrease
Valuation ($)
Valuation ($)
4 m
Valuation ($)
N/A
Valuation ($)
267.9 m
Valuation ($)
22.1 b
Valuation ($)
N/A
Twitter followers
Twitter followers
200
Twitter followers
2.8 k
Twitter followers
141
Twitter followers
10.1 k
Twitter followers
386
Number of tweets (last 30 days)
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
15
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
18
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
3.1
Average likes per tweet (last 30 days)
0.2
Average likes per tweet (last 30 days)
2.5
Average likes per tweet (last 30 days)
39.9
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
80%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
94.44%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
205541
Alexa Website Rank
548554
Alexa Website Rank
N/A
Alexa Website Rank
307236
Alexa Website Rank
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
4.5
Employee Rating
3.7
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
£131.2m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$60.6m (FY, 2017)
Net income
Net income
($2.2m) (FY, 2019)
Net income
£9.2m (FY, 2018)
Net income
($36.3m) (FY, 2019)
Net income
N/A
Net income
($163.4m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 8m
Total funding raised
N/A
Total funding raised
$ 139.8m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

LGC
HQ
Teddington, GB

LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.

View company
Chiasma
HQ
Needham, US
Employees
48

Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases.

View company
UCB
HQ
Anderlecht, BE
Employees
7,606↑ 9% increase

Patients are at the center of everything we do. At UCB, we are Inspired by patients. Driven by science.

View company
Keryx Biopharmaceuticals
HQ
New York, US

Keryx Biopharmaceuticals is a biopharmaceutical company focused on the development of products for the treatment of renal diseases.

View company